Africa Malaria Treatment Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Oct 2021
  • Country Level
  • 350 Pages
  • No of Tables: 123
  • No of Figures: 48

Africa Malaria Treatment Market, By Agent (Plasmodium Falciparum, P.Vivax, P.Ovale, P.Malariae, and P.Knowlelsi), Type (Medication, Vaccination, and Others), Treatment Type (Suppressive Treatment and Radical Treatment), Drug Type (Generics and Branded), Route of Administration (Oral and Parenteral), End User (Hospitals, Specialty Clinics, Home Healthcare and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Country (Nigeria, Democratic Republic of the Congo, Uganda, Niger, Côte d’Ivoire, Kenya, South Africa, Egypt and Rest of Africa) Industry Trends and Forecast to 2028.

Market Analysis and Insights : Africa Malaria Treatment Market

The Africa malaria treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.4% in the forecast period of 2021 to 2028 and is expected to reach USD 817,078.98 thousand by 2028 from USD 500,416.09 thousand in 2020.

Malaria is an infectious disease, which spreads through a bite of an infected female Anopheles mosquito, transferring parasites into the human body. Furthermore, these parasites lodge into liver cells, where they multiply and grow. They then move to red blood cells to reach a stage called merozoites. These merozoites grow inside the red cells and destroy them, which further cause symptoms such as fever, tiredness, vomiting, and headache. In addition, the drugs that are used to treat and prevent malarial infections are called antimalarial. There are different types of drugs, such as quinine, chloroquine, proguanil, mefloquine, pyrimethamine, and others, available in the market for the treatment of malarial infection.

The major factors that drive the Africa malaria treatment market are the increase in awareness initiatives by governments and surge in research for new antimalarial drugs. However, lack of awareness about healthcare in developing countries is a major factor restraining market growth. An increase in the production, import, and export of hydroxychloroquine and chloroquine is expected to act as an opportunity for the Africa malaria treatment market. Adverse effects and risks associated with anti-malaria drugs are expected to act as a challenge for the market.

Africa malaria treatment market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the Africa malaria treatment market scenario, contact Data Bridge Market Research for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.

Africa Malaria Treatment Market Africa Malaria Treatment Market Scope and Market Size

Africa malaria treatment market is segmented into seven notable segments based on agent, type, treatment, drug type, route of administration, end user and distribution channel.

  • On the basis of agent, the Africa malaria treatment market is segmented into Plasmodium Falciparum, P. Vivax, P. Ovale, P. Malariae, and P. Knowlelsi. In 2021, the Plasmodium Falciparum segment is expected to dominate the market due to its rapid transmission. Additionally, the climate condition and humidity of Sub-Saharan Africa enhance malaria transmission by plasmodium falciparum.
  • On the basis of type, the Africa malaria treatment market is segmented into medication, vaccination, and others. In 2021, the medication segment is expected to dominate the market because it is cost-effective, easily accessible, and primary treatment for the malaria patient pool.
  • On the basis of treatment type, the Africa malaria treatment market is segmented into suppressive treatment and radical treatment. In 2021, the suppressive treatment segment is expected to dominate the market because it is considered the primary and fundamental treatment. Moreover, the enormous demand for suppressive treatment worldwide acts as another driving factor for market growth.
  • On the basis of drug type, the Africa malaria treatment market is segmented into branded and generics. In 2021, the generics segment is expected to dominate the market because it is cost-effective compared to branded drugs. The growing demand for generics drugs from low and middle-income countries is another driving factor for market growth.
  • On the basis of route of administration, the Africa malaria treatment market is segmented into oral and parenteral. In 2021, the oral segment is expected to dominate the market because it is considered to be the first line of therapy. Moreover, the low manufacturing cost of tablets, capsules, and other orally administered drugs act as another driving factor for the market growth.
  • On the basis of end user, the Africa malaria treatment market is segmented into hospitals, specialty clinics, home healthcare, and others. In 2021, the hospitals segment is expected to dominate the market because of the increased healthcare expenditure by hospitals on advanced medical treatment.
  • On the basis of distribution channel, the Africa malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. In 2021, the direct tender segment is expected to dominate the market because of the surge in innovations and technologies, and the rising government funding is also propelling the market's growth.

Africa Malaria Treatment Market Africa Malaria Treatment Market Country Level Analysis

Africa malaria treatment market is segmented into seven notable segments based on agent, type, treatment, drug type, route of administration, end user and distribution channel.

The countries covered in the Africa malaria treatment market report are Nigeria, Democratic Republic of Congo, Uganda, Coste D’ Ivoire, Niger, Kenya, Egypt, South Africa, and the Rest of Africa. In the Africa malaria treatment market, Nigeria is expected to grow with the most promising growth due to the rapidly increasing patients and advancements in technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of African brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data. 

Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Africa Malaria Treatment Market

The Africa malaria treatment market also provides you with detailed market analysis for every country's growth in the malaria industry with its treatment sales, the impact of advancement in the malaria treatment market, and changes in regulatory scenarios with their support for the Africa malaria treatment market.

Competitive Landscape and Africa Malaria Treatment Market Share Analysis

The Africa malaria treatment market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Africa malaria treatment market.

Some major players operating in the Africa malaria treatment market are Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Zydus Cadila, Cipla Inc., GlaxoSmithKline plc., Bliss GVS Pharma Ltd., MMV, Novartis AG, Taj Pharmaceuticals Limited, Lupin Pharmaceuticals, Inc. (A Subsidiary of Lupin Limited), AJANTA PHARMA, Strides Pharma Science Limited, sanofi-aventis U.S. LLC (A Subsidiary of Sanofi), Viatris Inc., among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies worldwide, which also accelerates the Africa malaria treatment market.

  • In February 2018, Cipla Ltd. received confirmation of approval from the World Health Organization (WHO) Prequalification Programme for their 100mg rectal artesunate suppositories (RAS). It is for the pre-referral management of severe malaria. It has enhanced the market growth of the company
  • In July 2018, Lupin Pharmaceuticals, Inc. announced that its hydroxychloroquine sulfate tablets got approval from USFDA. The approval has accelerated the company's growth trajectory, particularly in the long term, which is anticipated to strengthen its position in the market

Collaboration, joint ventures, and other strategies by the market players are enhancing the company market in the Africa malaria treatment market, which also benefits the organization to improve their offering for medications.

Customization Available: Africa Malaria Treatment Market 

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 AFRICA MALARIA TREATMENT MARKET, PIPELINE ANALYSIS

TABLE 2 ESTIMATED MALARIA CASES AND DEATHS, BY REGION, 2018

TABLE 3 REGULATORY CHALLENGES TO ANTIMALARIAL DRUG APPROVAL.

TABLE 4 CHALLENGES AND PROBLEMS THAT DRIVE THE R&D FRAMEWORK

TABLE 5 AFRICA MALARIA TREATMENT MARKET, BY AGENT, 2019-2028 (USD THOUSAND)

TABLE 6 AFRICA MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 7 AFRICA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 8 AFRICA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 9 AFRICA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 10 AFRICA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 11 AFRICA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2019-2028 (USD THOUSAND)

TABLE 12 AFRICA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 13 AFRICA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 14 AFRICA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 15 AFRICA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 16 AFRICA MALARIA TREATMENT MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 17 AFRICA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD THOUSAND)

TABLE 18 AFRICA MALARIA TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD THOUSAND)

TABLE 19 NIGERIA MALARIA TREATMENT MARKET, BY AGENT, 2019-2028 (USD THOUSAND)

TABLE 20 NIGERIA MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 21 NIGERIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 22 NIGERIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 23 NIGERIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 24 NIGERIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 25 NIGERIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2019-2028 (USD THOUSAND)

TABLE 26 NIGERIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 27 NIGERIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 28 NIGERIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 29 NIGERIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 30 NIGERIA MALARIA TREATMENT MARKET, BY END USER 2019-2028 (USD THOUSAND)

TABLE 31 NIGERIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD THOUSAND)

TABLE 32 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY AGENT, 2019-2028 (USD THOUSAND)

TABLE 33 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 34 DEMOCRATIC REPUBLIC OF THE CONGO MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 35 DEMOCRATIC REPUBLIC OF THE CONGO ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 36 DEMOCRATIC REPUBLIC OF THE CONGO NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 37 DEMOCRATIC REPUBLIC OF THE CONGO VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 38 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2019-2028 (USD THOUSAND)

TABLE 39 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 40 DEMOCRATIC REPUBLIC OF THE CONGO BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 41 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 42 DEMOCRATIC REPUBLIC OF THE CONGO PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 43 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 44 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD THOUSAND)

TABLE 45 UGANDA MALARIA TREATMENT MARKET, BY AGENT, 2019-2028 (USD THOUSAND)

TABLE 46 UGANDA MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 47 UGANDA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 48 UGANDA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 49 UGANDA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 50 UGANDA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 51 UGANDA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2019-2028 (USD THOUSAND)

TABLE 52 UGANDA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 53 UGANDA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 54 UGANDA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 55 UGANDA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 56 UGANDA MALARIA TREATMENT MARKET, BY END USER 2019-2028 (USD THOUSAND)

TABLE 57 UGANDA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD THOUSAND)

TABLE 58 NIGER MALARIA TREATMENT MARKET, BY AGENT, 2019-2028 (USD THOUSAND)

TABLE 59 NIGER MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 60 NIGER MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 61 NIGER ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 62 NIGER NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 63 NIGER VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 64 NIGER MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2019-2028 (USD THOUSAND)

TABLE 65 NIGER MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 66 NIGER BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 67 NIGER MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 68 NIGER PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 69 NIGER MALARIA TREATMENT MARKET, BY END USER 2019-2028 (USD THOUSAND)

TABLE 70 NIGER MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD THOUSAND)

TABLE 71 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY AGENT, 2019-2028 (USD THOUSAND)

TABLE 72 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 73 CÔTE D’IVOIRE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 74 CÔTE D’IVOIRE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 75 CÔTE D’IVOIRE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 76 CÔTE D’IVOIRE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 77 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2019-2028 (USD THOUSAND)

TABLE 78 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 79 CÔTE D’IVOIRE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 80 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 81 CÔTE D’IVOIRE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 82 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY END USER 2019-2028 (USD THOUSAND)

TABLE 83 CÔTE D’IVOIRE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD THOUSAND)

TABLE 84 KENYA MALARIA TREATMENT MARKET, BY AGENT, 2019-2028 (USD THOUSAND)

TABLE 85 KENYA MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 86 KENYA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 87 KENYA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 88 KENYA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 89 KENYA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 90 KENYA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2019-2028 (USD THOUSAND)

TABLE 91 KENYA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 92 KENYA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 93 KENYA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 94 KENYA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 95 KENYA MALARIA TREATMENT MARKET, BY END USER 2019-2028 (USD THOUSAND)

TABLE 96 KENYA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD THOUSAND)

TABLE 97 SOUTH AFRICA MALARIA TREATMENT MARKET, BY AGENT, 2019-2028 (USD THOUSAND)

TABLE 98 SOUTH AFRICA MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 99 SOUTH AFRICA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 100 SOUTH AFRICA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 101 SOUTH AFRICA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 102 SOUTH AFRICA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 103 SOUTH AFRICA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2019-2028 (USD THOUSAND)

TABLE 104 SOUTH AFRICA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 105 SOUTH AFRICA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 106 SOUTH AFRICA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 107 SOUTH AFRICA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 108 SOUTH AFRICA MALARIA TREATMENT MARKET, BY END USER 2019-2028 (USD THOUSAND)

TABLE 109 SOUTH AFRICA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD THOUSAND)

TABLE 110 EGYPT MALARIA TREATMENT MARKET, BY AGENT, 2019-2028 (USD THOUSAND)

TABLE 111 EGYPT MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 112 EGYPT MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 113 EGYPT ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 114 EGYPT NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 115 EGYPT VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2019-2028 (USD THOUSAND)

TABLE 116 EGYPT MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2019-2028 (USD THOUSAND)

TABLE 117 EGYPT MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 118 EGYPT BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)

TABLE 119 EGYPT MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 120 EGYPT PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD THOUSAND)

TABLE 121 EGYPT MALARIA TREATMENT MARKET, BY END USER 2019-2028 (USD THOUSAND)

TABLE 122 EGYPT MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD THOUSAND)

TABLE 123 REST OF AFRICA MALARIA TREATMENT MARKET, BY AGENT, 2019-2028 (USD THOUSAND)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions